The Annals Evolution of Clinical Pharmacy | Now Available
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     


Published Online, 30 May 2006, www.theannals.com, DOI 10.1345/aph.1G404.
 The Annals of Pharmacotherapy: Vol. 40, No. 6, pp. 1125-1133. DOI 10.1345/aph.1G404
© 2006 Harvey Whitney Books Company.
This Article
Right arrow Abstract Freely available
Right arrow Extracto Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sabol, K. E
Right arrow Articles by Lewis, J. S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sabol, K. E
Right arrow Articles by Lewis, J. S, II

INFECTIOUS DISEASES

OBJECTIF:Discuter des infections à Staphylococcus aureus résistant à la méthicilline acquis en communauté (SARMAC) et évaluer les opportunités thérapeutiques des anciens antibiotiques.

SOURCE DES DONNÉES:MEDLINE, EMBASE, et la librairie Cochrane (1966-mai 2006) à l'aide des mots-clés: resistance de methicillin, acquise a la communauté, associée a la communauté, traitment, Staphylococcus aureus, mec, et Panton-Valentine leukocidin.

SÉLECTION DES ÉTUDES ET EXTRACTION DES DONNÉES:Tous les articles sont révisés de manière critique et les informations pertinentes sont incluses.

SYNTHESE DES DONNÉES:Il y a une tendance haussière chez les infections à SARMAC. Elles ont pour caractéristiques de ne pas être associées au milieu hospitalier, d'avoir un profil de sensibilité favorable, des génotypes distincts, des temps de génération rapides et des toxines additionnelles. Les options thérapeutiques incluent triméthoprim-sulfaméthoxazole, clindamycine, tétracyclines, fluoroquinolones, et des nouveaux antibiotiques.

CONCLUSIONS:Les infections à SARMAC peuvent être traitées adéquatement avec des anciens antibiotiques per os, comme le triméthoprim-sulfaméthoxazole, la clindamycine, et les tétracyclines. Les fluoroquinolones et le linézolide ne devraient pas être utilisés en première ligne.

www.theannals.com, DOI 10.1345/aph.1G404


This article has been cited by other articles:


Home page
 J Antimicrob ChemotherHome page
A. A. Vickers, N. J. Potter, C. W. G. Fishwick, I. Chopra, and A. J. O'Neill
Analysis of mutational resistance to trimethoprim in Staphylococcus aureus by genetic and structural modelling techniques
J. Antimicrob. Chemother., June 1, 2009; 63(6): 1112 - 1117.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
D. J. Elliott, T. E. Zaoutis, A. B. Troxel, A. Loh, and R. Keren
Empiric Antimicrobial Therapy for Pediatric Skin and Soft-Tissue Infections in the Era of Methicillin-Resistant Staphylococcus aureus
Pediatrics, June 1, 2009; 123(6): e959 - e966.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
L. S. Green, J. M. Bullard, W. Ribble, F. Dean, D. F. Ayers, U. A. Ochsner, N. Janjic, and T. C. Jarvis
Inhibition of Methionyl-tRNA Synthetase by REP8839 and Effects of Resistance Mutations on Enzyme Activity
Antimicrob. Agents Chemother., January 1, 2009; 53(1): 86 - 94.
[Abstract] [Full Text] [PDF]

Home page
 Am J Health Syst PharmHome page
R. A. Herman, V. R. Kee, K. G. Moores, and M. B. Ross
Etiology and treatment of community-associated methicillin-resistant Staphylococcus aureus
Am. J. Health Syst. Pharm., February 1, 2008; 65(3): 219 - 225.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
J. D. Szumowski, D. E. Cohen, F. Kanaya, and K. H. Mayer
Treatment and Outcomes of Infections by Methicillin-Resistant Staphylococcus aureus at an Ambulatory Clinic
Antimicrob. Agents Chemother., February 1, 2007; 51(2): 423 - 428.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
D. O Maclayton and R. G Hall II
Pharmacologic Treatment Options for Nosocomial Pneumonia Involving Methicillin-Resistant Staphylococcus aureus
Ann. Pharmacother., February 1, 2007; 41(2): 235 - 244.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
S. Phillips, C. MacDougall, and D. A Holdford
Analysis of Empiric Antimicrobial Strategies for Cellulitis in the Era of Methicillin-Resistant Staphylococcus aureus
Ann. Pharmacother., January 1, 2007; 41(1): 13 - 20.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Extracto Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sabol, K. E
Right arrow Articles by Lewis, J. S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sabol, K. E
Right arrow Articles by Lewis, J. S, II

homecopy help contact us subscription past issues search current issue
Copyright © 2006 by Harvey Whitney Books Company.